HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inga Liepelt-Scarfone Selected Research

Glucose (Dextrose)

12/2018Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson's disease.
1/2013Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Inga Liepelt-Scarfone Research Topics

Disease

36Parkinson Disease (Parkinson's Disease)
04/2024 - 01/2012
22Cognitive Dysfunction
01/2024 - 01/2012
22Dementia (Dementias)
01/2023 - 01/2011
3Synucleinopathies
01/2024 - 01/2020
3Alzheimer Disease (Alzheimer's Disease)
10/2018 - 09/2014
2Neurodegenerative Diseases (Neurodegenerative Disease)
01/2023 - 01/2021
2Prodromal Symptoms
09/2022 - 05/2020
1Disease Progression
01/2024
1Phenylketonurias (Phenylketonuria)
01/2021
1Atrophy
01/2021
1Dyscalculia
01/2021
1REM Sleep Behavior Disorder
01/2020
1Autoimmune Diseases of the Nervous System
01/2019
1Heart Diseases (Heart Disease)
01/2016
1Dyskinesias (Dyskinesia)
09/2015

Drug/Important Bio-Agent (IBA)

6Biomarkers (Surrogate Marker)IBA
09/2023 - 01/2011
4Glucosylceramidase (Glucocerebrosidase)IBA
04/2024 - 01/2013
4Amyloid (Amyloid Fibrils)IBA
01/2021 - 12/2017
3alpha-SynucleinIBA
01/2024 - 10/2018
3Levodopa (L Dopa)FDA LinkGeneric
01/2023 - 09/2015
3Proteins (Proteins, Gene)FDA Link
11/2021 - 09/2014
2SynucleinsIBA
01/2024 - 12/2014
2propylene diquat (PDQ(+))IBA
05/2020 - 01/2018
2Glucose (Dextrose)FDA LinkGeneric
12/2018 - 01/2013
2Apolipoproteins E (ApoE)IBA
01/2016 - 09/2014
2ApolipoproteinsIBA
01/2016 - 09/2014
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2022
1Neurotransmitter Agents (Neurotransmitter)IBA
11/2021
1Phenylalanine (L-Phenylalanine)FDA Link
01/2021
1Vecuronium Bromide (Vecuronium)FDA LinkGeneric
10/2020
1Immunoglobulin A (IgA)IBA
01/2019
1N-Methylaspartate (NMDA)IBA
01/2019
1Glutamate Receptors (Glutamate Receptor)IBA
01/2019
1Immunoglobulin G (IgG)IBA
01/2019
1Immunoglobulin M (IgM)IBA
01/2019
1AntibodiesIBA
01/2019
1AutoantibodiesIBA
01/2019
1vascular factorIBA
01/2016
1CeramidesIBA
01/2013
1ceramide monohexosideIBA
01/2013
1Glucosylceramides (Glucocerebrosides)IBA
01/2013
1CDw17 antigen (lactosylceramide)IBA
01/2013
1A-factor (Streptomyces)IBA
01/2012

Therapy/Procedure

19Activities of Daily Living (ADL)
01/2023 - 01/2012
4Cognitive Training
09/2023 - 01/2020